SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverHLN
HealthcareNYQUSD

Haleon plc

$0012345678900123456789.0012345678900123456789+11.2%
52w low (est.) $8.37$12.46 52w high (est.)
Market data
Market cap
USD43.42B
52-week range
USD8.65 – USD11.28
Beta (vs market)
0.24
Sector
Healthcare
Data quality
100/100
Valuation
P/E ratio
20.1x
DCF fair value
USD18.87
Margin of safety
+86.6%
Forward P/E
16.2x
PEG ratio
2.60
Dividend yield
1.98%
Quality & efficiency
Moat score
63/100
Return on equity
10.3%
Profit margin
15.1%
Debt / equity
0.52
Growth & analysts
Revenue growth (YoY)
+0.6%
Analyst target
USD11.65
Target upside
+15.2%
Analysts covering
5

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Valuation

ValueGrowthProfitHealthIncome54QUALITY
Overall Rating
74
Strong Buy
Strong Buy

Derived from filed metrics · High confidence (100% of the inputs available)

Moat Score63
DCF Intrinsic Value
USD18.87+86.6% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD43.42B
P/E Ratio
20.1
Dividend Yield
1.98%
Revenue Growth
+0.6%
Profit Margin
15.1%
ROE
10.3%
Debt / Equity
0.52
Beta
0.24
vs Healthcare sector:P/E 20 vs 28 · cheaperMoat 63 vs 7Yield 1.98% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · HLN